Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices

被引:103
|
作者
Jutabha, R
Jensen, DM
Martin, P
Savides, T
Han, SH
Gornbein, J
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Hlth Sci Ctr, Dept Med,Div Digest Dis, Los Angeles, CA USA
[2] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[3] Univ Calif San Diego, Med Ctr, Ctr Ulcer Res & Educ, Digest Dis Res Ctr, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Med Ctr, Cedars Sinai Med Ctr, San Diego, CA 92103 USA
[5] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA
关键词
D O I
10.1053/j.gastro.2005.01.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Standard care for prevention of first esophageal variceal hemorrhage is beta-blockade, but this may be ineffective or unsafe. Our purpose was to compare endoscopic banding with propranolol for prevention of first variceal hemorrhage. Methods: In a multicenter, prospective trial, 62 patients with cirrhosis with high-risk esophageal varices were randomized to propranolol (titrated to reducing resting pulse by 25%) or banding (performed monthly until varices were eradicated) and were followed up on the same schedule for a mean duration of 15 months. The primary end point was treatment failure, defined as the development of endoscopically documented variceal hemorrhage or a severe medical complication requiring discontinuation of therapy. Direct costs were estimated from Medicare reimbursements and fixed or variable charges for services up to treatment failure. Results: Background variables of the treatment groups were similar. The trial was stopped early after an interim analysis showed that the failure rate of propranolol was significantly higher than that of banding (6/31 vs. 0/31; difference, 1.9.4%; P =.0098; 95% confidence interval for true difference, 6.4%-37.2%). Significantly more propranolol than banding patients had esophageal variceal hemorrhage (4/31 vs. 0/31; difference, 12.9%; P =.0443; 95% confidence interval for true difference, 0.8%-29%), and the cumulative mortality rate was significantly higher in the propranolol than in the banding group (4/31 vs. 0/31; difference, 12.9%; P =.0443; 95% confidence interval for true difference, 0.8%-29%). Direct costs of care were not significantly different. Conclusions: For patients with cirrhosis with high-risk esophageal varices and no history of variceal hemorrhage, propranolol-treated patients had significantly higher failure rates of failure, first esophageal varix hemorrhage, and cumulative mortality than banding patients. Direct costs of medical care were not significantly different.
引用
收藏
页码:870 / 881
页数:12
相关论文
共 50 条
  • [31] The LIFE study: A randomized clinical trial of exercise to prevent disability in high-risk older persons
    Guralnik, J
    JOURNAL OF AGING AND PHYSICAL ACTIVITY, 2004, 12 (03) : 343 - 343
  • [32] INOVASIA Study: A Multicenter Randomized Clinical Trial of Pravastatin to Prevent Preeclampsia in High-Risk Patients
    Akbar, Muhammad Ilham Aldika
    Azis, Muhammad Alamsyah
    Riu, Deviana Soraya
    Wawengkang, Ellen
    Ernawati, Ernawati
    Bachnas, Muhammad Adrianes
    Sulistyowati, Sri
    Dachlan, Erry Gumilar
    Mose, Johanes Cornelius
    Dekker, Gus
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 (09) : 1203 - 1211
  • [33] MONILIA ESOPHAGITIS ASSOCIATED WITH ESOPHAGEAL VARICEAL SCLEROTHERAPY (EVS) - A PROSPECTIVE-STUDY DEFINING A NEW HIGH-RISK GROUP
    SARLES, HE
    SANOWSKI, RA
    BELLAPRAVALU, S
    HAYNES, WC
    GASTROINTESTINAL ENDOSCOPY, 1984, 30 (02) : 157 - 157
  • [34] PREVENTIVE TREATMENT OF RECURRENT HEMORRHAGE OF ESOPHAGEAL-VARICES (VO) IN ALL CIRRHOTIC SUBJECTS - ENDOSCOPIC SCLEROSIS OR PROPRANOLOL - PRELIMINARY-RESULTS OF A RANDOMIZED PROSPECTIVE-STUDY
    BADER, R
    CLAUDE, P
    PLANCHON, F
    SONTAG, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1986, 10 (01): : 76 - 77
  • [35] A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (Tiss study)
    Bergamasco, B
    Benna, P
    Carolei, A
    Rasura, M
    Rudelli, G
    Fieschi, C
    FUNCTIONAL NEUROLOGY, 1997, 12 (01) : 33 - 43
  • [36] Efficacy and safety of carvedilol in cirrhosis patients with uncomplicated ascites without high-risk esophageal varices-a randomized controlled trial [NCT05057572]
    Khajuria, Rahul
    Jindal, Ankur
    Sarin, Shiv Kumar
    JOURNAL OF HEPATOLOGY, 2024, 80 : S6 - S6
  • [37] Unilateral ovarian polyfollicular aspiration does not prevent severe ONSS in high-risk patients: a prospective randomized study
    Egbase, PE
    Maksheed, M
    AlSharhan, M
    Grudzinskas, JG
    HUMAN REPRODUCTION, 1997, 12 : P39 - P39
  • [38] PROPHYLACTIC SCLEROTHERAPY FOR ESOPHAGEAL-VARICES IN HIGH-RISK CIRRHOTIC-PATIENTS SELECTED BY ENDOSCOPIC AND HEMODYNAMIC CRITERIA - A RANDOMIZED, SINGLE-CENTER CONTROLLED TRIAL
    PAQUET, KJ
    KALK, JF
    KLEIN, CP
    GAD, HA
    ENDOSCOPY, 1994, 26 (09) : 734 - 740
  • [39] A PROSPECTIVE RANDOMIZED STUDY OF CEREBROSPINAL-FLUID DRAINAGE TO PREVENT PARAPLEGIA AFTER HIGH-RISK SURGERY ON THE THORACOABDOMINAL AORTA
    CRAWFORD, ES
    SVENSSON, LG
    HESS, KR
    SHENAQ, SS
    COSELLI, JS
    SAFI, HJ
    MOHINDRA, PK
    RIVERA, V
    JOURNAL OF VASCULAR SURGERY, 1991, 13 (01) : 36 - 46
  • [40] A non-randomized retrospective observational study on the subcutaneous esophageal reconstruction after esophagectomy: is it feasible in high-risk patients?
    Chung, Jae Ho
    Lee, Sung Ho
    Yi, Eunjue
    Jung, Jae Seung
    Han, Jung Wook
    Kim, Tae Sik
    Son, Ho Sung
    Kim, Kwang Taik
    JOURNAL OF THORACIC DISEASE, 2017, 9 (03) : 675 - 684